Cloricromene conjugates with short-chain alkylamino acids: Synthesis and biological evaluation

Drug Development Research

Volumn 57, Issue 3, 2002, Pages 115-121

  Pignatello, Rosario ^a   Puleo, Antonina ^a   Giustolisi, Simona ^a   Cuzzocrea, Salvatore ^b   Dugo, Laura ^b   Caputi, Achille P ^b   Puglisi, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Biological tests; Cloricromene; Conjugates; Lipophilic; Synthesis

Indexed keywords

AMINO ACID DERIVATIVE; CLORICROMEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG BINDING; DRUG CONJUGATION; DRUG EFFICACY; DRUG STABILITY; DRUG SYNTHESIS; ENZYMATIC DEGRADATION; HYPOTENSION; LIPOPHILICITY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SEPTIC SHOCK; STRUCTURE ACTIVITY RELATION;

EID: 0036869493     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10118     Document Type: Article

References (23)

1. Bertocchi F, Breviario F, Proserpio P, Wang JM, Ghezzi P, Travagli RA, Prosdocimi M, Dejana E. 1989. In vitro inhibition of human polymorphonuclear cell function by cloricromene. Naunyn-Schmiederbers Arch Pharmacol 339:697-703.
2. Birnabaum SM, Fu SCJ, Greenstain JP. 1953. Resolution of the racemic α-amino derivatives of heptylic, caprylic, nonylic, decylic and undecylic acids. J Biol Chem 203:333-338.
3. Caputi AP, Rossi F, Carney K, Brezenoff HE. 1980. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J Pharmacol Exp Ther 215:309-316.
4. Colucci M, Balconi G, Lorenzet R, et al. 1983. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71:1893-1896.
5. Dinaerman JL, Mehta JL. 1990. Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanism and their clinical relevance. J Am Coll Cardiol 16:207-222.
6. 2 formation in human platelets. Pharmacol Res Commun 12:329-337.
7. Gibbons WA, Hughes RA, Charalambous M, Christodoulou M, Aulabaugh AE, Mascagni P, Toth I. 1990. Synthesis, resolution and structural elucidation of lipidic amino acid and their homo-and hetero-oligomers. Liebigs Ann Chem 1175-1183.
8. Hakim G, Fiorentini D, Falasca A, Prosdocimi M, Rossi CA. 1988. Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy-carbonyl-methoxy coumarin) on cyclic nucleotide phosphodiesterases in human platelets. Experientia 44: 226-228.
9. Hughes RA, Toth I, Ward P, Ireland SJ, Gibbons WA. 1991. Lipidic peptides. III. Lipidic amino acid and oligomer conjugates of morphine. J Pharm Sci 80:1103-1105.
10. Hussain R, Toth I, Gibbons WA. 1991. Lipidic peptides. VII. Synthesis and structure elucidation of γ-amino-butyric acid conjugates with lipidic acids, lipidic amino acids and lipidic peptides. Liebigs Ann Chem 963-966.
11. Oguri T, Kawai N, Shioiri T, Yamada SI. 1978. Amino acids and peptides XXIX. A new efficient asymmetric synthesis of α-amino acid derivatives with recycle of a chiral reagent-asymmetric alkylation of a chiral Shiff base from glycine. Chem Pharm Bull 26:803-808.
12. Pignatello R, Jansen G, Kathmann I, Puglisi G, Toth I. 1998. Lipoamino acid conjugates of methotrexate with antitumor activity. J Pharm Sci 87:367-371.
13. Pignatello R, Spampinato G, Sorrenti V, Di Giacomo C, Vicari L, McGuire JJ, Russell CA, Puglisi G, Toth I. 2000. Lipophilic methotrexate conjugates with antitumor activity. Eur J Pharm Sci 10:237-245.
14. Pignatello R, Vicari L, Sorrenti V, Di Giacomo C, Spampinato G, Puglisi G, Toth I. 2001. Lipophilic methotrexate conjugates with glucose-lipoamino acid moieties: synthesis and in vitro antitumor activity. Drug Dev Res 52:454-461.
15. 2 activity in human platelets stimulated with trombin. Agents Actions 29:364-373.
16. Squadrito F, Altavilla D, Zingarelli B, Ioculano M, Calapai G, Campo GM, Miceli A, Prosdocimi M, Caputi AP. 1993. The effect of cloricromene, a coumarine derivative, on leukocyte accumulation, myocardial necrosis and TFA-alpha production in myocardial ischaemis-reperfusion injury. Life Sci 53:341-355.
17. Sturniolo R, Squadrito F, Altavilla D, Trimarchi GR, Prosdocimi M, Caputi AP. 1989. Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats. Circ Shock 28:267-277.
18. Sturniolo R, Squadrito F, Campo GM, Vinci R, Calatroni A, Prosdocimi M, Caputi AP. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat. 1991. J Cardiovasc Pharmacol 17:261-266.
19. Toth I. 1994. A novel chemical approach to drug delivery: lipidic amino acid conjugates. J Drug Targeting 2:217-239.
20. Toth I, Hughes RA, Munday M, Mascagni P, Gibbons WA. 1991. Lipidic peptides. II. Synthesis, activity and transport of antiinflammatory benzoquinolizine lipidic peptide conjugates. Int J Pharm 68:191-198.
21. Travagli RA, Zatta A, Banzatto N, et al. 1989. Molecular aspects of cloricromene (AD6) distribution in human platelets and its pharmacological effects. Thromb Res 54:327-338.
22. Wood IP, Toth I, Holley JL, Gibbons WA. 1992. Lipidic peptides. XIII. Synthesis, structure elucidation, and in vitro toxicity assessment of chlorambucil conjugates with lipidic acids, lipidic amino acids and their oligomers. Int J Pharm 87:141-147.
23. Zanetti A, Zatta A, Prosdocimi M, Dejana E. 1986. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-methoxy coumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine. Eur J Pharmacol 128:119-127.